CanadaHow to identify it
ITOVEBI, inavolisib tablets, 3 mg and 9 mg.
The hazard
Two cases of life-threatening or fatal ketoacidosis have been reported in diabetic patients treated with ITOVEBI in the post-market setting.
What to do
See Key Messages below
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)